Events

  • The Integral and International Lung Cancer Consortium (ILCCO) Annual Meetings will be held at International Agency for Research on Cancer, 150 Cours Albert-Thomas, Lyon, France. There will be four (4) main themes: Genomics/Etiology, Biomarkers, Screening, and Clinical Outcome.

  • The Integral Component of the ILCCO meeting, will occur at International Agency for Research on Cancer, 150 Cours Albert-Thomas, Lyon, France, in the afternoon of September 5th, 2019 afternoon

  • The World Conference on Lung Cancer will be held in Barcelona, Spain. There will be a lung cancer screening workshop on September 6th, 2019

Introduction

Broad scientific aims that can be addressed through the consortium include:

Biomarkers of lung cancer risk Extensive pilot data strongly supports the use of biomarkers in lung cancer risk prediction models. Within Project 2 we will systematically evaluate a comprehensive panel of promising risk biomarkers using pre- diagnostic blood samples. This will result in a selected panel of biomarkers of lung cancer risk that will be incorporated in risk prediction models, and used to identify those subjects most likely to benefit from CT- screening.